BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38199869)

  • 1. Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study.
    Rosenvilde JJ; Lauritsen J; Bandak M; Wagner T; Agerbæk M; Dysager L; Aagaard M; Daugaard G
    Eur Urol Oncol; 2024 Jun; 7(3):589-596. PubMed ID: 38199869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Thor A; Grenabo Bergdahl A; Almås B; Håkansson U; Törnblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Sagstuen Haugnes H; Engen Andreassen K; Melsen Larsen S; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2022 Apr; 5(2):235-243. PubMed ID: 33750683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
    Woldu SL; Moore JA; Ci B; Freifeld Y; Clinton TN; Aydin AM; Singla N; Laura-Maria K; Hutchinson RC; Amatruda JF; Sagalowsky A; Lotan Y; Arriaga Y; Margulis V; Xie Y; Bagrodia A
    Eur Urol Oncol; 2018 Aug; 1(3):242-251. PubMed ID: 31058267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
    Paffenholz P; Pfister D; Heidenreich A
    Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer.
    Li R; Duplisea JJ; Petros FG; González GMN; Tu SM; Karam JA; Huynh TT; Ward JF
    Eur Urol Oncol; 2021 Aug; 4(4):651-658. PubMed ID: 31412007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
    Riggs SB; Burgess EF; Gaston KE; Merwarth CA; Raghavan D
    Oncologist; 2014 May; 19(5):498-506. PubMed ID: 24718515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
    Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
    World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
    Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
    Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
    Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postchemotherapy retroperitoneal residual mass resection for germ cell testicular tumors: a single-center experience.
    Kalemci S; Kizilay F; Ergun KE; Aliyev B; Simsir A
    Rev Assoc Med Bras (1992); 2022 Apr; 68(4):524-529. PubMed ID: 35649078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
    Antonelli L; Ardizzone D; Tachibana I; Adra N; Cary C; Hugar L; Sexton WJ; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Cazzaniga W; Nicol D; Gerdtsson A; Tandstad T; Fizazi K; Fankhauser CD;
    J Clin Oncol; 2023 Dec; 41(34):5296-5305. PubMed ID: 37656935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
    Ghoreifi A; Mitra AP; McClintock G; Baky F; McDowell Z; Lavallée E; Saoud R; Cai J; Gill IS; Sfakianos J; Porter J; Bagrodia A; Ahmadi N; Eggener S; Ward JF; Djaladat H
    Urol Oncol; 2023 Feb; 41(2):111.e7-111.e14. PubMed ID: 36437156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
    Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
    Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.